Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade® to Remsima®? An Observational Study.
Xue L, van Bilsen K, Schreurs MWJ, van Velthoven MEJ, Missotten TO, Thiadens AAHJ, Kuijpers RWAM, van Biezen P, Dalm VASH, van Laar JAM, Hermans MAW, Dik WA, van Daele PLA, van Hagen PM.
Xue L, et al. Among authors: hermans maw.
Front Med (Lausanne). 2020 Aug 6;7:418. doi: 10.3389/fmed.2020.00418. eCollection 2020.
Front Med (Lausanne). 2020.
PMID: 32850911
Free PMC article.